Postdialysis serum phosphate equilibrium in hemodialysis patients on a controlled diet and no binders

被引:5
作者
Stremke, Elizabeth R. [1 ,2 ]
Trevino, Laurie [2 ]
Doshi, Simit [3 ]
Moorthi, Ranjani N. [3 ]
Gallant, Kathleen M. Hill [1 ,4 ]
Moe, Sharon M. [2 ,3 ,5 ]
机构
[1] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA
[2] Indiana Univ, Indiana Clin & Translat Sci Inst, Indianapolis, IN 46204 USA
[3] Indiana Univ, Sch Med, Dept Med, Div Nephrol, Indianapolis, IN USA
[4] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA
[5] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN USA
关键词
diet; hemodialysis; phosphorus; CHRONIC KIDNEY-DISEASE; PHOSPHORUS CONCENTRATION; MINERAL METABOLISM; MORTALITY; HYPERPHOSPHATEMIA; KINETICS; REMOVAL; CALCIUM; FGF23; RISK;
D O I
10.1111/hdi.12999
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Studies evaluating the change in serum phosphate post hemodialysis (HD) demonstrate an initial decline during dialysis but a rebound post dialysis. However, previous studies were done on usual diet and phosphate binders, with limited number of blood draws, confounding conclusions. We determined serum phosphate reduction, rebound, and equilibrium over 48 h in HD patients consuming a controlled, low phosphorus diet without binders. Methods Serum phosphate (mg/dL) was analyzed before and after a HD treatment and frequently during the ensuing 48 h intradialytic period in the clinical research unit. Thirteen subjects were enrolled and had been off phosphate binders for 10 days and consumed a standardized low phosphate (900 mg/day) diet for 3 weeks prior to the assessments. Linear regression was used to determine relationships between the pre-HD serum phosphate, decline post-HD (post-HD drop); and a 48 h area under curve (AUC) using the trapezoidal method as a measure of overall phosphate levels from the end of dialysis to 48 h post dialysis. Repeated Measures ANOVA with Dunnett's posthoc test was used to determine rebound. Results Five of 13 subjects returned to >90% of their pre-HD serum phosphate within the first 24 h post-HD, and serum phosphate was 94 +/- 0.11% (range 63%-113%) by 48 h after the completion of HD. The 48 h AUC of serum phosphate during the interdialytic period was correlated with both pre dialysis phosphorus (r = 0.85; p = 0.0002) and the pre-post drop in serum phosphate during dialysis (r = 0.69; p = 0.0085). In contrast, the net ultrafiltration was not related to the 48 h AUC of serum phosphorus (r = 0.20; p = 0.51). Conclusions In hemodialysis patients on standard low phosphorus diet and no phosphate binders, the interdialytic serum phosphorus level, assessed as AUC, is determined by the pre dialysis potassium and net-change in serum phosphorus during the dialysis treatment, but not the ultrafiltration volume.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 35 条
[1]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[2]   Educational Strategies to Reduce Serum Phosphorus in Hyperphosphatemic Patients With Chronic Kidney Disease: Systematic Review With Meta-analysis [J].
Caldeira, Daniel ;
Amaral, Tiago ;
David, Claudio ;
Sampaio, Cristina .
JOURNAL OF RENAL NUTRITION, 2011, 21 (04) :285-294
[3]   The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis [J].
Chang, Wen Xiu ;
Xu, Ning ;
Kumagai, Takanori ;
Shiraishi, Takeshi ;
Kikuyama, Takahiro ;
Omizo, Hiroki ;
Sakai, Kazuhiro ;
Arai, Shigeyuki ;
Tamura, Yoshifuru ;
Ota, Tatsuru ;
Shibata, Shigeru ;
Fujigaki, Yoshihide ;
Shen, Zhong Yang ;
Uchida, Shunya .
PLOS ONE, 2016, 11 (04)
[4]   Pathophysiology of Vascular Calcification [J].
Chen, Neal X. ;
Moe, Sharon M. .
CURRENT OSTEOPOROSIS REPORTS, 2015, 13 (06) :372-380
[5]   Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Raggi, P .
KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252
[6]   Control of hyperphosphatemia among patients with ESRD [J].
Coladonato, JA .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 :S107-S114
[7]   Removal of Phosphorus by Hemodialysis [J].
Daugirdas, John T. .
SEMINARS IN DIALYSIS, 2015, 28 (06) :620-623
[8]  
DESOI CA, 1993, J AM SOC NEPHROL, V4, P1214
[9]   FGF23 induces left ventricular hypertrophy [J].
Faul, Christian ;
Amaral, Ansel P. ;
Oskouei, Behzad ;
Hu, Ming-Chang ;
Sloan, Alexis ;
Isakova, Tamara ;
Gutierrez, Orlando M. ;
Aguillon-Prada, Robier ;
Lincoln, Joy ;
Hare, Joshua M. ;
Mundel, Peter ;
Morales, Azorides ;
Scialla, Julia ;
Fischer, Michael ;
Soliman, Elsayed Z. ;
Chen, Jing ;
Go, Alan S. ;
Rosas, Sylvia E. ;
Nessel, Lisa ;
Townsend, Raymond R. ;
Feldman, Harold I. ;
Sutton, Martin St. John ;
Ojo, Akinlolu ;
Gadegbeku, Crystal ;
Di Marco, Giovana Seno ;
Reuter, Stefan ;
Kentrup, Dominik ;
Tiemann, Klaus ;
Brand, Marcus ;
Hill, Joseph A. ;
Moe, Orson W. ;
Kuro-o, Makoto ;
Kusek, John W. ;
Keane, Martin G. ;
Wolf, Myles .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (11) :4393-4408
[10]   Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population [J].
Floege, Juergen ;
Kim, Joseph ;
Ireland, Elizabeth ;
Chazot, Charles ;
Drueke, Tilman ;
de Francisco, Angel ;
Kronenberg, Florian ;
Marcelli, Daniele ;
Passlick-Deetjen, Jutta ;
Schernthaner, Guntram ;
Fouqueray, Bruno ;
Wheeler, David C. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (06) :1948-1955